Obalon Therapeutics, Inc. ($OBLN) published 1Q20 Loss of $ 0.68 per share from the revenue of $ 0.78 million
[redirect url=’https://www.cms.stockmarketintellects.com/company-dashboard/?symbol=OBLN’ sec=’1′]
Obalon Therapeutics, Inc. ($OBLN) published 1Q20 Loss of $ 0.68 per share from the revenue of $ 0.78 million
[redirect url=’https://www.cms.stockmarketintellects.com/company-dashboard/?symbol=OBLN’ sec=’1′]
